Este documento presenta un formato para informes de avance de proyectos que incluye secciones para el título, investigadores, número de inscripción, grupo e línea de investigación, logros, objetivos, avances, limitantes, y un cronograma propuesto vs ejecutado. El formato consta de 8 páginas y provee una estructura estandarizada para reportar el progreso de un proyecto.
How to Make Awesome SlideShares: Tips & TricksSlideShare
Turbocharge your online presence with SlideShare. We provide the best tips and tricks for succeeding on SlideShare. Get ideas for what to upload, tips for designing your deck and more.
How to Make Awesome SlideShares: Tips & TricksSlideShare
Turbocharge your online presence with SlideShare. We provide the best tips and tricks for succeeding on SlideShare. Get ideas for what to upload, tips for designing your deck and more.
Cancer is a complex, heteroge- neous genetic disease caused by some cancer driver muta- tion which is located not only in exon region but non-coding region. Hence, whole-genome sequencing (WGS) of cancer is a powerful tool for detecting and analyzing the entire DNA make-up of cancer tissue in single run. It allows rapid and deep capture of a large number of cancer-related variations including single nucleotide variants, small insertion/dele- tions,and copynumber variants. By comparing tumor with normal DNA, the unique DNA mutations present in cancer tissue are discovered, which may provide key information for genetic mecha- nism and pathogenesis of cancer, and provide a basis for disease diagnosis. https://www.creative-biolabs.com/suprecision/
The sequencing principles of common sequencing instruments on the market: (1) first, construct a DNA template library. Obtain DNA library fragments (tens to hundreds of bases in length) by randomly breaking genomic DNA, or construct paired-end fragments that control the distance distribution. Adapter sequences were ligated to both ends of the DNA fragment and then denatured to obtain a single-stranded template library and immobilized on a solid surface. (2) Second, amplify the clones, which performed by one of several methods, such as bridge PCR and emulsion PCR. (3) Then, forming DNA clusters or amplifying microspheres of DNA cluster arrays on a chip, performing a series of cyclic reaction operations using a polymerase\ or ligase, and monitoring the optical events generated in each cycle biochemical reaction by a microscopic detection system. Time series analysis of the resulting array images is performed to obtain sequences of DNA fragments. These fragments are then assembled into longer contigs according to certain computer algorithms.
Creative Biolabs uses the advanced SuPrecision™ platform to support researchers all over the world with their sequencing needs for cancer.www.creative-biolabs.com/suprecision
Cancer is a complex, heteroge- neous genetic disease caused by some cancer driver muta- tion which is located not only in exon region but non-coding region. Hence, whole-genome sequencing (WGS) of cancer is a powerful tool for detecting and analyzing the entire DNA make-up of cancer tissue in single run. It allows rapid and deep capture of a large number of cancer-related variations including single nucleotide variants, small insertion/dele- tions,and copynumber variants. By comparing tumor with normal DNA, the unique DNA mutations present in cancer tissue are discovered, which may provide key information for genetic mecha- nism and pathogenesis of cancer, and provide a basis for disease diagnosis. https://www.creative-biolabs.com/suprecision/
The sequencing principles of common sequencing instruments on the market: (1) first, construct a DNA template library. Obtain DNA library fragments (tens to hundreds of bases in length) by randomly breaking genomic DNA, or construct paired-end fragments that control the distance distribution. Adapter sequences were ligated to both ends of the DNA fragment and then denatured to obtain a single-stranded template library and immobilized on a solid surface. (2) Second, amplify the clones, which performed by one of several methods, such as bridge PCR and emulsion PCR. (3) Then, forming DNA clusters or amplifying microspheres of DNA cluster arrays on a chip, performing a series of cyclic reaction operations using a polymerase\ or ligase, and monitoring the optical events generated in each cycle biochemical reaction by a microscopic detection system. Time series analysis of the resulting array images is performed to obtain sequences of DNA fragments. These fragments are then assembled into longer contigs according to certain computer algorithms.
Creative Biolabs uses the advanced SuPrecision™ platform to support researchers all over the world with their sequencing needs for cancer.www.creative-biolabs.com/suprecision
PREVENCION DELITOS RELACIONADOS COM INT.pptxjohnsegura13
Concientizar y sensibilizar a los funcionarios, sobre la importancia de promover la seguridad en sus operaciones de comercio internacional, mediante la unificación de criterios relacionados con la trazabilidad de sus operaciones.
El análisis PESTEL es una herramienta estratégica que examina seis factores clave del entorno externo que podrían afectar a una empresa: políticos, económicos, sociales, tecnológicos, ambientales y legales.
1. SISTEMA DE GESTIÓN DE LA CALIDAD Página 1 de 8
FORMATO PARA LA PRESENTACIÓN DE Código: IN-P01-F02
INFORME DE AVANCE Versión: 01
1. TITULO DEL PROYECTO:
2. INVESTIGADORES:
NOMBRE TIEMPO ASIGNADO
3. NÚMERO DE INSCRIPCIÓN:
4. GRUPO DE INVESTIGACIÒN: Sin grupo
5. LÍNEA DE INVESTIGACIÓN: Sin línea
6. INFORME No. FECHA INFORME:
7. FECHA DE INICIO: 8. FECHA DE FINALIZACIÓN:
9. LOGROS DEL PROYECTO:
• Número de artículos originados del proyecto*:
• Número de trabajos de grado iniciados y/o terminados*:
• Número de ponencias en eventos especializados*:
• Número de estudiantes vinculados al proyecto:
* Anexar Soporte
2. SISTEMA DE GESTIÓN DE LA CALIDAD Página 2 de 8
FORMATO PARA LA PRESENTACIÓN DE Código: IN-P01-F02
INFORME DE AVANCE Versión: 01
10. OBJETIVOS:
Objetivo Porcentaje
Descripción Actividades
No. de Avance
3. SISTEMA DE GESTIÓN DE LA CALIDAD Página 3 de 8
FORMATO PARA LA PRESENTACIÓN DE Código: IN-P01-F02
INFORME DE AVANCE Versión: 01
11. AVANCE EN EL CUMPLIMIENTO DE LOS OBJETIVOS (1 Pág.):
4. SISTEMA DE GESTIÓN DE LA CALIDAD Página 4 de 8
FORMATO PARA LA PRESENTACIÓN DE Código: IN-P01-F02
INFORME DE AVANCE Versión: 01
12. LIMITANTES EN EL DESARROLLO DE LAS ACTIVIDADES (1 Pág.):
5. SISTEMA DE GESTIÓN DE LA CALIDAD Página 5 de 8
FORMATO PARA LA PRESENTACIÓN DE Código: IN-P01-F02
INFORME DE AVANCE Versión: 01
13. CRONOGRAMA Y CUMPLIMIENTO:
Tiempo (meses)
Actividad
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
P
E
P
E
P
E
P
E
P
E
P
E
6. SISTEMA DE GESTIÓN DE LA CALIDAD Página 6 de 8
FORMATO PARA LA PRESENTACIÓN DE Código: IN-P01-F02
INFORME DE AVANCE Versión: 01
P
E
P
E
P
E
P: actividad propuesta – E: Actividad Ejecutada
7. SISTEMA DE GESTIÓN DE LA CALIDAD Página 7 de 8
FORMATO PARA LA PRESENTACIÓN DE Código: IN-P01-F02
INFORME DE AVANCE Versión: 01
13. CRONOGRAMA Y CUMPLIMIENTO (Continuación):
Tiempo (meses)
Actividad
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
P
E
P
E
P
E
P
E
P
E
P
E
P
8. SISTEMA DE GESTIÓN DE LA CALIDAD Página 8 de 8
FORMATO PARA LA PRESENTACIÓN DE Código: IN-P01-F02
INFORME DE AVANCE Versión: 01
E
P
E
P
E
P: actividad propuesta – E: Actividad Ejecutada
